hi sal, agree 100% with ambs post ...plenty to cheer about and any one a game changer ...and appears ambs weathered the US Supreme Court june gene patent ruling. my particular point is that gerald's continued (needed) dilution will hamper any price run in the short term...long term, diluting $5mil appears minor with potential gains. inclined toward dr jerry post of early 2014 for ambs.